Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
30 May 2024
General meetings, Regulated information
2024 AGM
Open in new window
30 May 2024
Regulated information
quorum
Open in new window
29 May 2024
General Assembly, General meetings
Compensation policy of the Chief Executive Officer and/or any other corporate officer
Open in new window
23 May 2024
Regulated information
Monthly Information regarding the total number of voting rights
Open in new window
07 May 2024
General Assembly, General meetings
Rapport AK réservée aux salariés
Open in new window
07 May 2024
General Assembly, General meetings
Rapport sur OCA
Open in new window
07 May 2024
General Assembly, General meetings
Rapport attribution AGA
Open in new window
07 May 2024
General Assembly, General meetings
Rapport sur attribution de SO
Open in new window
07 May 2024
General Assembly, General meetings
Rapport sur attribution de BSA
Open in new window
07 May 2024
General Assembly, General meetings
Rapport délégation globale
Open in new window
View previous 9 articles
1
2
3
4
5
6
7
…
21
View next 9 articles
Go back to the page of the page